Inova Schar Cancer Institute Recruiting Patients for ASCO’s Groundbreaking TAPUR Clinical Trial

inova logo

Trial Will Learn From Use of Approved Targeted Cancer Therapies Matched to Tumor Genomic Profile Falls Church, VA — Inova Schar Cancer Institute announced today it is recruiting patients for the American Society of Clinical Oncology’s (ASCO) first-ever clinical trial, the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. The trial will evaluate molecularly targeted…

Read More

IBA to Install Proton Therapy Facility at the Inova Schar Cancer Institute in Virginia, USA

inova logo

Contract signed with Inova for two-room Proteus®PLUS* proton therapy system near IBA’s North American Headquarters Reston, VA, USA, July 5th, 2017 – IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions for the treatment of cancer, and Inova, a global leader in personalized health, today signed a contract for a two-room…

Read More

Colon Cancer in Young Adults: Know Your Risk

Timothy L. Cannon, MD, is a member of Inova Medical Group board certified in medical oncology and hematology. He has a special interest in managing of gastrointestinal cancers. Read Dr. Cannon’s profile. March is Colorectal Cancer Awareness Month, and I always applaud efforts to raise awareness of this disease – the fourth most common cancer…

Read More

Inova Schar Cancer Institute Oncologist Jeanny Aragon-Ching Selected for ASCO Leadership Development Program

inova logo

FALLS CHURCH, VA – Inova is pleased to announce that Jeanny Aragon-Ching, MD, has been selected to participate in the esteemed American Society of Clinical Oncology (ASCO) Leadership Development Program for years 2017-2018. The ASCO Leadership Development Program is a year-long course for a mid-career group of highly accomplished practicing oncologists. It positions them to…

Read More